retatrutide korea approval vs. Tirzepatide Medical Weight Loss | Start

On concentrations, South Korea's Ministry of Food and Drug Safety has set 0.04% as the approved functional anti-wrinkle level

doi: 10.3945/ajcn.2010.28674F [PubMed] [Elsevier] Cory, H., Passarelli, S., Szeto, J., Tamez, M., & Mattei, J

Safety Considerations Not everything works for everyone

Most patients have mild skin reactions, while severe (grade 3-4) toxicities are found in a low proportion of patients (5.8% for the ipilimumab + nivolumab combination, even lower values for anti-PD-1 monotherapy), significantly lower than the toxicities of other sites (such as hepatic or gastrointestinal) (129)

& Gainetdinov, R